Douglas B. Given, Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), bought 655 shares at $66.37 ($43K) on 2021-12-28, disclosed to the SEC on 2021-12-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ARWR | SELL | 2023-05-08 | $266K | — | Filing → |
| ARWR | SELL | 2023-03-01 | $29K | — | Filing → |
| ARWR | SELL | 2021-09-10 | $326K | — | Filing → |